Literature DB >> 21559972

Development time of IgG antibodies to West Nile virus.

Anna Papa1, Kostas Danis, Katerina Tsergouli, Katerina Tsioka, Elpida Gavana.   

Abstract

Following an outbreak of West Nile virus (WNV) infections in Greece during summer/autumn 2010, a study was conducted to investigate the patterns of WNV IgG reactivity in 255 patients with respect to the day of illness and the type of clinical syndrome. IgG antibodies were detectable after a mean of 8.1 ± 4.9 and 12.6 ± 11.3 days after onset of illness in neuroinvasive and non-neuroinvasive cases, respectively (p < 0.001), suggesting that a delay in the development of WNV IgG antibodies is seen in non-neuroinvasive cases.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21559972     DOI： 10.1007/s00705-011-1014-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  3 in total

Review 1.  West Nile virus state of the art report of MALWEST Project.

Authors:  Andriani Marka; Alexandros Diamantidis; Anna Papa; George Valiakos; Serafeim C Chaintoutis; Dimitrios Doukas; Persefoni Tserkezou; Alexios Giannakopoulos; Konstantinos Papaspyropoulos; Eleni Patsoula; Evangelos Badieritakis; Agoritsa Baka; Maria Tseroni; Danai Pervanidou; Nikos T Papadopoulos; George Koliopoulos; Dimitrios Tontis; Chrysostomos I Dovas; Charalambos Billinis; Athanassios Tsakris; Jenny Kremastinou; Christos Hadjichristodoulou; Nikolaos Vakalis; Evdokia Vassalou; Spyridoula Zarzani; Athanassios Zounos; Katerina Komata; Georgios Balatsos; Stavroula Beleri; Anastasia Mpimpa; Vasilios Papavasilopoulos; Ioannis Rodis; Grigorios Spanakos; Nikolaos Tegos; Vasiliki Spyrou; Zisis Dalabiras; Periklis Birtsas; Labrini Athanasiou; Maria Papanastassopoulou; Charalambos Ioannou; Christos Athanasiou; Christos Gerofotis; Elpida Papadopoulou; Theodolinta Testa; Ourania Tsakalidou; George Rachiotis; Nikolaos Bitsolas; Zissis Mamouris; Katerina Moutou; Theologia Sarafidou; Konstantinos Stamatis; Konstantina Sarri; Sotirios Tsiodras; Theano Georgakopoulou; Marios Detsis; Maria Mavrouli; Anastasia Stavropoulou; Lida Politi; Georgia Mageira; Varvara Christopoulou; Georgia Diamantopoulou; Nikolaos Spanakis; Georgia Vrioni; Evangelia-Theofano Piperaki; Kornilia Mitsopoulou; Ilias Kioulos; Antonios Michaelakis; Ioannis Stathis; Ioannis Tselentis; Anna Psaroulaki; Maria Keramarou; Dimosthenis Chochlakis; Yeorgios Photis; Maria Konstantinou; Panagiotis Manetos; Stylianos Tsobanoglou; Spyros Mourelatos; Vasilis Antalis; Panagiotis Pergantas; Georgios Eleftheriou
Journal:  Int J Environ Res Public Health       Date:  2013-12-02       Impact factor: 3.390

2.  Emergence of West Nile virus lineage 2 in Europe: Characteristics of the first seven cases of West Nile neuroinvasive disease in horses in Austria.

Authors:  Phebe de Heus; Jolanta Kolodziejek; Jeremy V Camp; Katharina Dimmel; Zoltán Bagó; Zdenek Hubálek; René van den Hoven; Jessika-M V Cavalleri; Norbert Nowotny
Journal:  Transbound Emerg Dis       Date:  2019-12-24       Impact factor: 5.005

3.  Antibody responses in humans infected with newly emerging strains of West Nile Virus in Europe.

Authors:  Stefan Chabierski; Gustavo R Makert; Alexandra Kerzhner; Luisa Barzon; Petra Fiebig; Uwe G Liebert; Anna Papa; Justin M Richner; Matthias Niedrig; Michael S Diamond; Giorgio Palù; Sebastian Ulbert
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.